Similar articles

• Surreptitious drug use by patients in a panic disorder study.

  Clark DB, Taylor CB, Roth WT, Hayward C, Ehlers A, Margraf J, Agras WS. Clark DB, et al. Am J Psychiatry. 1990 Apr;147(4):507-9. doi: 10.1176/ajp.147.4.507. Am J Psychiatry. 1990. PMID: 1969248 Clinical Trial.
• Medication discontinuation in panic disorder.

  Ballenger JC, Pecknold J, Rickels K, Sellers EM. Ballenger JC, et al. J Clin Psychiatry. 1993 Oct;54 Suppl:15-21; discussion 22-4. J Clin Psychiatry. 1993. PMID: 8262887 Review.
• Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.

  [No authors listed] [No authors listed] Br J Psychiatry. 1992 Feb;160:191-202; discussion 202-5. doi: 10.1192/bjp.160.2.191. Br J Psychiatry. 1992. PMID: 1540759 Clinical Trial.
• Growing placebo response rate: the problem in recent therapeutic trials?

  Uhlenhuth EH, Matuzas W, Warner TD, Thompson PM. Uhlenhuth EH, et al. Psychopharmacol Bull. 1997;33(1):31-9. Psychopharmacol Bull. 1997. PMID: 9133749 Clinical Trial.
• Efficacy studies of alprazolam in panic disorder.

  Spiegel DA. Spiegel DA. Psychopharmacol Bull. 1998;34(2):191-5. Psychopharmacol Bull. 1998. PMID: 9640999 Review.